抄録
The impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (RCC) is discussed herein with consideration of prolonged survival and quality of life. A nephrectomy can be indicated in a patient with good performance status and pulmonary metastases when adjuvant immunotherapy is an option. In contrast, in a patient with poor performance status and/or metastases including multiple organs, a nephrectomy is not indicated. To relieve symptoms, options other than nephrectomy should be considered.
| 本文言語 | English |
|---|---|
| ページ（範囲） | 1732-1737 |
| ページ数 | 6 |
| ジャーナル | Gan to kagaku ryoho. Cancer & chemotherapy |
| 巻 | 29 |
| 号 | 10 |
| 出版ステータス | Published - 2002 10月 |
ASJC Scopus subject areas
- 腫瘍学
- 癌研究
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
